Diagnosis of tuberculosis IN Patients in end-stage chronic kidney disease

DOI: https://doi.org/10.29296/25877305-2020-02-05
Download full text PDF
Issue: 
2
Year: 
2020

O. Gordeeva, N. Karpina, MD Central Research Institute of Tuberculosis, Moscow

In the category of persons with secondary immunodeficiency, the number of patients with end-stage chronic kidney disease is growing annually. Tuberculosis incidence and mortality among these patients are ten times higher than those in the general population. The diagnosis of tuberculosis in patients with chronic kidney disease is extremely difficult: the manifestation of the tuberculosis process does not have a characteristic clinical and radiological pattern; etiological verification rarely reaches 50%, and the possibility of immunodiagnosis of tuberculosis has not been insufficiently investigated.
Keywords: 
фтизиатрия
нефрология
диагностика туберкулеза
хроническая болезнь почек в терминальной стадии
диализ
трансплантация почки
иммунодиагностика

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Tareeva E.I. (red.) Nefrologija. Rukovodstvo dlja vrachej. 2-e izd., pererab. i dop. / M.: Meditsina, 2000; 687 s. [Tareeva E.I. (red.) Nefrologiya. Rukovodstvo dlya vrachei. 2-e izd., pererab. i dop. / M.: Meditsina, 2000; 687 s. (in Russ.)]
  2. Summary reports of 2016 [Electronic resource]. Global observatory on donation and transplantation activities. Mode of access: http://www.transplant-observatory.org/reports/
  3. Neirynck N., Vanholder R., Schepers E. et al. An update on uremic toxins // Int. Urol. Nephrol. – 2013; 45: 139–50. DOI: 10.1007/s11255- 012-0258-1.
  4. Papakrivopoulou E., Booth J., Pinney J. et al. Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients // Nephron Extra. – 2012; 2 (1): 48–54. DOI: 10.1159/000337338.
  5. Scherban' N.A. Endobronhial'naja mikrogemotsirkuljatsija i kliniko-morfofunktsional'naja harakteristika patologicheskih protsessov v bronholegochnoj sisteme u bol'nyh hronicheskoj bolezn'ju pochek (kliniko-eksperimental'noe issledovanie). Dis. ... d-ra med. nauk. Blagoveschensk, 2011; 248 s. [Shcherban’ N.A. Endobronkhial’naya mikrogemotsirkulyatsiya i kliniko-morfofunktsional’naya kharakteristika patologicheskikh protsessov v bronkholegochnoi sisteme u bol’nykh khronicheskoi bolezn’yu pochek (kliniko-eksperimental’noe issledovanie). Dis. ... d-ra med. nauk. Blagoveshchensk, 2011; 248 s. (in Russ.)].
  6. Ates G., Yildiz T., Danis R. et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region // Renal failure. – 2010; 32 (1): 91–5. DOI: 10.3109/08860220903367528.
  7. Moore D., Lightstone L., Javid B. et al. High rates of tuberculosis in end-stage renal failure: the impact of international migration // Emerg. Infect. Dis. – 2002; 8 (1): 77–8. DOI: 10.3201/eid0801.010017.
  8. Rao T., Ram R., Swarnalatha G. et al. Tuberculosis in haemodialysis patients: A single centre experience // Indian J. Nephrol. – 2013; 23 (5): 340–5. DOI: 10.4103/0971-4065.116296.
  9. Christopoulos A., Diamantopoulos A., Dimopoulos P. et al. Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial // BMC Nephrology. – 2009; 10 (1): 36. DOI: 10.1186/1471-2369-10-36.
  10. Unsal A., Elbis A., Taner B. et al. Tuberculosis in dialysis patients: a nine-year retrospective analysis // J. Infect. Dev. Ctries. – 2013; 7 (3): 208–13. DOI: 10.3855/jidc.2664.
  11. Chou K., Fang H., Bai K. et al. Tuberculosis in maintenance dialysis patients // Nephron. – 2001; 88 (2): 138–43. DOI: 10.1159/000045974.
  12. Muñoz P., Rodriguez S., Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants // Clin. Infect. Dis. – 2005; 40 (4): 581–7. DOI: 10.1086/427692.
  13. Agafonova S.G., Prokopenko E.I. Tuberkulez u bol'nyh s terminal'noj hronicheskoj pochechnoj nedostatochnost'ju (Obzor literatury) // Nefrologija i dializ. – 2004; 6 (2): 108–16 [Agafonova S.G., Prokopenko E.I. Tuberculosis in patients with end-stage renal disease // Nefrologiya i dializ. – 2004; 6 (2): 108–16 (in Russ.)].
  14. Cavusoglu C., Cicek-Saydam C., Karasu Z. et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid organ transplant recipients // Clin. Transplant. – 2002; 16 (4): 257–61. DOI: 10.1034/j.1399-0012.2002.01098.x.
  15. Reis-Santos B., Gomes T., Horta B. et al. Tuberculosis prevalence in renal transplant recipients: systematic review and meta-analysis // Brazil. J. Nephrol. – 2013; 35 (3): 206–13. DOI: 10.5935/0101-2800.20130033.
  16. Canet E. Incidence et prognostic de l`infection a mycobacterium tuberculosis dans le cohort multicentrique de patients transplantesrenaux en France de 1986 a 2006: Diplomed`etat de docteur un medicine / Nantes, 2008; 67 r.
  17. Vatazin A.V., Prokopenko E.I., Perlin D.V. i dr. Osobennosti diagnostiki tuberkuleza u bol'nyh hronicheskoj pochechnoj nedostatochnost'ju na programmnom gemodialize i posle transplantatsii pochki // Nefrologija i dializ. – 1999; 1 (1): 39–44 [Vatazin A.V., Prokopenko E.I., Perlin D.V. et al. Osobennosti diagnostiki tuberkuleza u bol’nykh khronicheskoi pochechnoi nedostatochnost’yu na programmnom gemodialize i posle transplantatsii pochki // Nefrologiya i dializ. – 1999; 1 (1): 39–44 (in Russ.)].
  18. Abdelrahman M., Sinha A., Karkar A. Tuberculosis in end stage renal disease patients on hemodialysis // Hemodialysis Int. – 2006; 10 (4): 360–4. DOI: 10.1111/j.1542-4758.2006.00130.x.
  19. Kayabasi H., Sit D., Kadiroglu A. et al. The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in southeast Turkey // Renal failure. – 2008; 30 (5): 513–9. DOI: 10.1080/08860220802064721.
  20. Hussein M., Mooij J., Roujouleh H. Tuberculosis and chronic renal disease // Semin. Dial. – 2003; 16 (1): 38–44.
  21. Yang, W., Han F., Zhang X. et al. Extra-pulmonary tuberculosis infection in the dialysis patients with end stage renal diseases: case reports and literature review // Journal of Zhejiang University SCIENCE B. – 2013; 14 (1): 76–82. DOI: 10.1631/jzus.B1200244.
  22. Segall L., Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy // Clin. J. Am. Soc. Nephrol. – 2010; 5 (6): 1114–22. DOI: 10.2215/CJN.09231209.
  23. Higuita L., Nieto-Rios J., Daguer-Gonzalez S. et al. Tuberculosis in renal transplant patients: The experience of a single center in Medellin-Colombia, 2005-2013 // Brazil. J. Nephrol. – 2014; 36 (4): 512–8. DOI: 10.5935/0101-2800.20140073.
  24. Usta A., Shawish T., Mishra A. et al. Living related kidney transplantation in Libya: a single center experience // Transplant. Proc. – 2008; 40: 3428–33. DOI: 10.1016/j.transproceed.2008.06.063.
  25. Jebali H., Barrah S., Rais L. et al. The diagnosis of tuberculosis in dialysis patients// Saudi J. Kidney Dis. Transplant. – 2017; 28 (6): 1362–8. DOI: 10.4103/1319-2442.220882.
  26. Lakadamyali H., Lakadamyali H., Ergun T. Thorax CT findings in symptomatic hemodialysis patients // Transplant. Proc. – 2008; 40 (1): 71–6. DOI: 10.1016/j.transproceed.2007.11.037.
  27. Federal'nye klinicheskie rekomendatsii po organizatsii i provedeniju mikrobiologicheskoj i molekuljarno-geneticheskoj diagnostiki tuberkuleza / M., 2014; s. 10–8. [Federal’nye klinicheskie rekomendatsii po organizatsii i provedeniyu mikrobiologicheskoi i molekulyarno-geneticheskoi diagnostiki tuberkuleza / M., 2014; s. 10–8 (in Russ.)].
  28. Kane Y., Faye M., Lemrabott A. Relevance of the GeneXpert Test for the Diagnosis of TB in Chronic Hemodialysis Patients in Casamance, South of Senegal // J. Kidney. – 2016; 2: 133. DOI: 10.4172/2472-1220.1000133.
  29. ATS/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection // Am. J. Respir. Crit. Care Med. – 2000; 161: 1376–95.
  30. Simon H. Mycobacterial and nocardial infections in the compromised host. Clinical approach to infection in the compromised host. R.H. Rubin, L.S. Young (eds.). 2nd ed. / New York: Plenum, 1988; 221–51.
  31. Poduval R., Hammes M. Tuberculosis screening in dialysis patients – is the tuberculin test effective? // Clin. Nephrol. – 2003; 59 (6): 436–40.
  32. Pril. №4 k Prikazu Minzdrava Rossii ot 21.03.2003 №109 «Instruktsija po primeneniju tuberkulinovyh prob» (v red. Prikaza Minzdravsotsrazvitija RF ot 29.10.2009 №855) [Pril. №4 k Prikazu Minzdrava Rossii ot 21.03.2003 g. №109 «Instruktsiya po primeneniyu tuberkulinovykh prob» (v red. Prikaza Minzdravsotsrazvitiya RF ot 29.10.2009 №855) (in Russ.)].
  33. Slogotskaya. L.V., Litvinov V., Ovsyankina E. et al. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection // Paediatric Resp. Rev. – 2013; 14 (2): S65.
  34. Slogotskaya L.V., Bogorodskaya E., Sentchichina O. et al. Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children // Eur. Resp. J. – 2015; 46 (S59): RA4524.
  35. Shovkun L., Aksenova V., Kudlay D. et al. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA) // Eur. Resp. J. – 2018; 52 (Suppl. 62): PA2733.
  36. Slogotskaya L.V., Litvinov V., Kudlay D.A. et al. New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection // Eur. Resp. J. – 2012; 40 (S56): 416.
  37. Starshinova A.A., Kudlaj D.A., Dovgaljuk I.F. i dr. Effektivnost' primenenija novyh metodov immunodiagnostiki tuberkuleznoj infektsii v Rossijskoj Federatsii // Pediatrija. – 2019; 98 (4): 229–35 [Starshinova A.A., Kudlay D.A., Dovgalyuk I.F. et al. Efficacy of new methods of tuberculosis infection immunodiagnostics in the Russian Federation // Pediatria. – 2019; 98 (4): 229–35 (in Russ.)]. DOI: 10.24110/0031-403X-2019-98-4-229-235
  38. Pai M., Riley L., Colford J. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review // Lancet Infect. Dis. – 2004; 4 (12): 761–76. DOI: 10.1016/S1473-3099(04)01206-x.
  39. Mazurek G., Jereb J., Vernon A. et al. Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection // MMWR Recomm. Rep. – 2010; 59 (RR-5): 1–25.
  40. Inoue T., Nakamura T., Katsuma A. et al. The value of QuantiFERON® TB-Gold in the diagnosis of tuberculosis among dialysis patients // Nephrol. Dial. Transplant. – 2009; 24 (7): 2252–7.
  41. Lai C., Tan C., Liao C. et al. Diagnosis of pulmonary tuberculosis among dialysis patients by enzyme-linked immunospot assay for interferon-γ // Nephrol. Dial. Transplant. – 2009; 24 (8): 2605–6. DOI: 10.1093/ndt/gfp224.
  42. Ferguson T., Tangri N., Macdonald K. et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis // Transplantation. – 2015; 99 (5): 1084–91. DOI: 10.1097/TP.0000000000000451.
  43. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management / Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
  44. Canadian Tuberculosis Committee: Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS) // Can. Commun. Dis. Rep. – 2008; 34: 1–13.
  45. National Tuberculosis Advisory Committee: Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection [Electronic resource]. Australian Government, Department of Health and Ageing. – Mode of access: Available at http://www.health.gov.au/internet/m-ain/pub¬lishing.nsf/Content/cdna-ntac-interferon.htm
  46. Japan Society for Tuberculosis: Guideline for the use of Quantiferon TB-2G. Committee of TB Prevention // Kekkaku. – 2013; 88 (1): 33–7.
  47. Health Protection Agency of UK: Position statement on the use of Interferon Gamma Release Assay (IGRA) tests for tuberculosis (TB) [Electronic resource] // Public Health England. – Mode of access: http://www.hpa.org.uk/web/HPA¬webFile/HPAweb_C/1214808549127
  48. Swiss Lung League: Detection of latent tuberculosis using a blood test (interferon-gamma) [Electronic resource] / Berne, Swiss Federal Office of Public Health. – Mode of access: http://www.sgpp-schweiz.ch/downloads_cms/gamma-interferontest_bag_7_11_05.pdf
  49. Position statement on the use of the new immunological tests for the diagnosis of latent tuberculosis infection [Electronic resource] / Infections and Tuberculosis Study Groups of the Italian Hospital Pulmonology Association and the Italian Society of Respiratory Medicine // Aiponet. – Mode of access: http://www.aiponet.it/download/1617.pdf (in Italian).
  50. Committee for Practical Tuberculosis Control: Positioning of interferon gamma release assays in the diagnosis of tuberculosis [Electronic resource] // NVMM. – Mode of access: http://www.nvmm.nl/nvmm/nvmmcms.nsf/uploads/16D33316B-72BA199C12573FB0043D583/$FILE/251.101%20Plaatsbepaling-%20IGRA%20oktober%202007.pdf (in Dutch).
  51. French National Authority for Health: Interferon gamma release assays for the diagnosis of Tuberculosis infection [Electronic resource] // HAS. – Mode of access: http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_detec¬tion_de_linterferon-gamma.pdf (in French).
  52. National TB Advisory Committee: Guidelines on the prevention and control of tuberculosis in Ireland [Electronic resource] // HPSC. – Mode of access: http://www.hpsc.ie/hpsc/A-Z/VaccinePreventable/TuberculosisTB/Publications/-ConsultationDocuments/File.2991.en.pdf
  53. Dridi A., Kaaroud H., Boubaker K. et al. Tuberculosis in renal transplant recipients // Transplant. Proc. – 2003; 7 (35): 2682–3. DOI: 10.1016/j.transproceed.2003.08.064.
  54. Aguado J., Torre-Cisneros J., Fortún J. et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology // Clin. Infect. Dis. – 2009; 48 (9): 1276–84. DOI: 10.1086/597590.
  55. Anand M., Nayyar E., Concepcion B. et al. Tuberculosis in kidney transplant recipients: a case series // World J. Transplant. – 2017; 7 (3): 213–21. DOI: 10.5500/wjt.v7.i3.213.
  56. Meije Y., Piersimoni C., Torre-Cisneros J. et al. Mycobacterial infections in solid organ transplant recipients // Clin. Microbiol. Infect. – 2014; 20 (7): 89–101. DOI: 10.1111/1469-0691.12641.
  57. Artjuhina L.Ju., Ivanova E.S., Frolova N.F. i dr. Osobennosti techenija tuberkuleznoj infektsii na fone immunosupressii u retsipientov pochki // Lechebnoe delo. – 2015; 1: 11–7 [Artyukhina L.Yu., Ivanova E.S., Frolova N.F. et al. Tuberculosis in Kidney Transplant Recipients // Lechebnoe delo. – 2015; 1: 11–7 (in Russ.)].
  58. Sundaram M., Adhikary S., John G. et al. Tuberculosis in renal transplant recipients // Indian J. Urol. – 2008; 24 (3): 396–400. DOI: 10.4103/0970-1591.42625.
  59. Klinicheskie rekomendatsii «Diagnostika, lechenie i profilaktika infektsionnyh oslozhnenij u patsientov s transplantirovannoj pochkoj» / M.: Nauchnoe obschestvo nefrologov Rossii, Assotsiatsija nefrologov Rossii, 2014 [Klinicheskie rekomendatsii «Diagnostika, lechenie i profilaktika infektsionnykh oslozhnenii u patsientov s transplantirovannoi pochkoi» / M.: Nauchnoe obshchestvo nefrologov Rossii, Assotsiatsiya nefrologov Rossii, 2014 (in Russ.)].